Artificial intelligence is moving from the lab into the clinic, and one of its most provocative promises is that it might ...

Background Non-communicable diseases (NCDs) are the leading cause of death and morbidity worldwide, responsible for 7 out of ...

Only a handful of major companies have yet to report their results for the last quarter, and AI leader Oracle is one of them.

Will the future of enterprise AI hinge on data streaming engineers and organizations closing the gap between knowing and ...

Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ...

Where you live may matter more than you think when it comes to your health. A new study has found that people living in ...

People are now betting on everything. Prediction markets are amplifying those signals. The timing of the U.S. government shutdown. The likelihood of Taylor Swift canceling a tour date. The exact day ...

Novo Nordisk has decided to move its amycretin into pivotal trials in type 2 diabetes after a phase 2 readout, having already started preparing phase 3 studies of the dual GLP-1 and amylin agonist as ...

A Scientific Reports study developed a pattern neural network that integrates total antioxidant status with clinical and ...